Xiyun Chai

机构：AbbVie (United States)

发表论文 24 篇 · 总被引 6320 次 · h-index 12

代表论文

• Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders (2020 · JAMA · 被引 1637)
• Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020 · Nature Medicine · 被引 1300)
• Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration (2020 · Nature Medicine · 被引 813)
• Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography (2018 · Alzheimer s & Dementia · 被引 670)
• Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease (2020 · Nature Communications · 被引 463)
• Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease (2020 · Science Advances · 被引 383)